Biotech and life sciences occupiers in Nairobi typically cluster in Gigiri (UN Corridor), plan ~320 sqft per seat at high-end fit-out ($10600–16000/sqft), and pay around 1300 KES/sqft ($11 USD) on Class A.
Biotech and life sciences occupiers in Nairobi typically cluster in Gigiri (UN Corridor), plan ~320 sqft per seat at high-end fit-out">fit-out ($10600–16000/sqft), and pay around 1300 KES/sqft ($11 USD) on Class A.
Biotech and life sciences occupiers in Nairobi typically anchor in Gigiri (UN Corridor). UN agencies, NGOs, embassies, diplomatic services.
Class A rent in Nairobi runs 1300 KES/sqft ($11 USD) on a 5-year lease with 6 months free. Prime submarkets sit at or modestly above the city index.
Typical biotech and life sciences fit-out targets high-end specification at $10600–16000/sqft. Branded reception, full client-facing programming, premium furniture, and specialist AV are standard.
Plan around 320 sqft per seat blended (workstation + circulation + amenity). A 100-headcount biotech office in Nairobi typically targets 32,000 sqft of leasable area.
Cluster effects are decisive: PhD-grade talent concentrates near academic-medical anchors and translational research institutes. Deep mobile money / fintech, NGO, and African operations talent. Strong English and Swahili bilingual professional base. Strong feed from University of Nairobi, Strathmore, and JKUAT.
Headline corporate tax: 30%. Net leases. 5-6 year terms with escalation clauses. Free rent of 4-8 months and TI of KES 4,000-7,000/sqm typical.
| city | Nairobi |
|---|---|
| industry | Biotech and life sciences |
| naics | 541714, 541715, 325412 |
| preferredSubmarket | Gigiri (UN Corridor) |
| preferredFitoutSpec | High-end |
| fitoutBand | $10600–16000/sqft |
| sqftPerSeat | 320 |
| classARentLocal | 1300 KES/sqft/yr |
| classARentUsd | $11/sqft/yr |
| vacancyPct | 21.4% |
| typicalLeaseYears | 5 |
| typicalRentFreeMonths | 6 |
| talentIndex | 72 |
| corporateTaxPct | 30% |
Reviewed by Samuel Okafor — EMEA contributing editor. Last updated 2026-04-15. See our methodology and editorial standards.